Safimaltib
Product Specifications
UNSPSC Description
Safimaltib (JNJ-67856633) is an orally active, first-in-class, potent, selective and allosteric MALT1 protease inhibitor. Safimaltib in some cases lead to tumor stasis[1][2][3].
Target Antigen
MALT1
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease;NF-κB
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/safimaltib.html
Smiles
O=C(C1=C(C(F)(F)F)N(C2=CC=CC3=C2C=CNC3=O)N=C1)NC4=CC(C(F)(F)F)=NC=C4
Molecular Weight
467.32
References & Citations
[1]Virtual meeting delivers first time drug structures|[2]A Phase 1, First-in-Human, Open-Label Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-67856633, an Inhibitor of MALT1, in Participants with NHL and CLL|[3]Abstract 5690: Discovery of JNJ-67856633: A novel, first-in-class MALT1 protease inhibitor for the treatment of B cell lymphomas
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-139399/Safimaltib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139399/Safimaltib-SDS-MedChemExpress.pdf
CAS Number
2230273-76-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6453410-01 0.1 mL
RAGE, NT (Receptor for Advanced Glycosylation End Products) (MaxLight 750)
Ask
View Details 
MBS6453410-02 5x 0.1 mL
RAGE, NT (Receptor for Advanced Glycosylation End Products) (MaxLight 750)
Ask
View Details 